Related Experiment Video
Updated: May 13, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Endovascular intervention in acute deep vein thrombosis
1Interventional Radiology The Mount Sinai Medical Center New York, NY, USA. jaskirat.virk@mountsinai.org
Deep venous thrombosis (DVT) treatments are reviewed, highlighting conventional anticoagulation and newer therapies. Pharmacomechanical thrombolysis (PMT) shows promise as a low-risk, effective option for acute DVT, often in outpatient settings.
Area of Science:
- Vascular Medicine
- Interventional Cardiology
- Thrombosis Research
Background:
- Deep venous thrombosis (DVT) is a prevalent condition with significant acute and chronic morbidity, including post-thrombotic syndrome (PTS).
- Conventional anticoagulation for DVT has limitations, with many patients experiencing long-term complications.
- Existing therapies for acute DVT aim for rapid clot lysis but vary in efficacy and risk.
Purpose of the Study:
- To review current systemic, surgical, and endovascular therapies for acute deep venous thrombosis (DVT).
- To evaluate the efficacy, risks, and benefits of various DVT treatment modalities based on existing literature.
- To highlight the emerging role and potential of pharmacomechanical thrombolysis (PMT) in DVT management.
Main Methods:
- Literature review of systemic, surgical, and endovascular treatments for DVT.
- Analysis of efficacy, risks, and benefits reported in current scientific publications.
- Focus on pharmacomechanical thrombolysis (PMT) as a specific treatment modality.
Main Results:
- Conventional anticoagulation is standard but associated with significant long-term morbidity.
- Various thrombolytic strategies exist, with differing outcomes and risk profiles.
- Pharmacomechanical thrombolysis (PMT) demonstrates low risk and high efficacy for acute DVT, suitable for outpatient treatment.
Conclusions:
- Pharmacomechanical thrombolysis (PMT) represents a promising, transformative therapy for acute deep venous thrombosis (DVT).
- Further research is needed to fully establish the utility of PMT in diverse clinical settings.
- Optimizing DVT treatment remains crucial to reduce patient burden and socioeconomic costs.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
